Quick Answer
Viatris Inc reported Research And Development Expense of $751.10 million for the year ending 2021.
- Viatris Inc showed an increase of +35.3% in Research And Development Expense from 2020 to 2021.
- This data is from Viatris Inc's annual report (Form 10-K), filed with the SEC on February 28, 2022.
- XBRL data for this metric is available from 2018 to 2021 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: $114.20 million | Q2 2020: $156.30 million | Q3 2020: $129.80 million | Q1 2021: $184.10 million | Q2 2021: $147.70 million | Q3 2021: $152.10 million | Q1 2022: $142.30 million | Q2 2022: $162.60 million | Q3 2022: $174.90 million | Q1 2023: $182.90 million | Q2 2023: $208.30 million | Q3 2023: $211.20 million | Q1 2024: $199.70 million | Q2 2024: $204.10 million | Q3 2024: $198.40 million | Q1 2025: $222.00 million | Q2 2025: $218.80 million | Q3 2025: $250.40 million.
- Over the full 4 years of available data (2018 to 2021), Viatris Inc's Research And Development Expense has grown by 6.6%.
- Historical annual values: Fiscal year 2021: $751.10 million | Fiscal year 2020: $555.10 million | Fiscal year 2019: $639.90 million | Fiscal year 2018: $704.50 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: